Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2003
11/27/2003US20030219877 Novel epothilone compounds and methods for making the same
11/27/2003CA2486138A1 Methods of using thiazolidinedithione derivatives
11/27/2003CA2485367A1 Diaminothiazoles
11/27/2003CA2484324A1 Methods using a combination of a 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia
11/27/2003CA2484233A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003CA2484011A1 Cysteine protease inhibitors
11/26/2003EP1364949A1 Jnk inhibitor
11/26/2003EP1364946A1 Isoxazoline derivative and herbicide comprising the same as active ingredient
11/26/2003EP1364040A2 Degradation of epothilones and ethynyl substituted epothilones
11/26/2003EP1363903A1 Indole derivatives and their use as gnrh antagonists
11/26/2003EP1363902A1 Chemical compounds
11/26/2003EP1363899A1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
11/26/2003EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363897A2 Antagonists of mcp-1 function and methods of use thereof
11/26/2003EP1363891A2 Anthrone derivatives and their use as jnk inhibitors
11/26/2003EP1363887A1 Substituted quinolinecarboxamides as antiviral agents
11/26/2003EP1363884A2 Pyridine-substituted benzanilides as potassium ion channel openers
11/26/2003EP1363881A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
11/26/2003EP1363638A2 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
11/26/2003EP1363637A1 Pyrimidine compounds and methods for making and using the same
11/26/2003EP1363635A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
11/26/2003EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1000028B1 Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
11/26/2003EP0757038B1 Benzamide compound and medicinal use thereof
11/26/2003CN1458932A 3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acid derivatives as anti-bacterial agents
11/26/2003CN1458931A Tartrate salts of thiazolidinedione derivative
11/26/2003CN1458930A Tartrate salts of thiazolidinedione derivative
11/26/2003CN1458929A Chemokine receptor binding heterocyclic compounds
11/26/2003CN1458928A N-substituted benzothiophenesulfonamide derivatives
11/26/2003CN1128790C 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
11/26/2003CN1128617C Preparation method for medicinal composition containing triazolyl derivative
11/25/2003US6653478 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide Y modulators
11/25/2003US6653340 2-amidino-5 or 6-benzofuranyl or benzothiophenyl 2-furanyl, thiophenyl or benzyl carboxylates; serine protease inhibitors potent against Factor D of the alternate complement pathway
11/25/2003US6653331 Targeted drug delivery using sulfonamide derivatives
11/25/2003US6653330 Amide-type triazole compounds
11/25/2003US6653316 Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
11/25/2003US6653314 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
11/25/2003US6653312 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/25/2003US6653306 Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy
11/25/2003US6653304 Antiarthritic agents; skin disorders; anticarcinogenic agents
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/25/2003CA2163028C New thiazolidinediones and pharmaceutical agents containing them
11/20/2003WO2003095445A1 New organic compounds for electroluminescence and organic electroluminescent devices using the same
11/20/2003WO2003095441A1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
11/20/2003WO2003095438A1 Substituted phenylacetamides and their use as glucokinase activators
11/20/2003WO2003095435A1 Amide derivatives
11/20/2003WO2003095434A1 Benzoxazine derivatives as 5-ht6 modulators and uses thereof
11/20/2003WO2003095430A1 Substituted pyrazolyl compounds for the treatment of inflammation
11/20/2003WO2003094861A2 Bis-benzimidazoles and related compounds as potassium channel modulators
11/20/2003WO2003094853A2 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
11/20/2003WO2003051276A3 Therapeutic heterocycles
11/20/2003WO2003029210A3 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
11/20/2003WO2003017946A3 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
11/20/2003WO2003006447A3 Interaction inhibitors of tcf-4 with beta-catenin
11/20/2003WO2002102315A3 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
11/20/2003WO2002064558A3 Oxazole derivatives, their preparation and their use as cytokine inhibitors
11/20/2003US20030216571 Tricyclic compounds
11/20/2003US20030216569 Viricides; Aids therapy
11/20/2003US20030216452 Method of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substitute indolealkanoic acids
11/20/2003US20030216450 Inhibitors of dipeptidyl peptidase IV
11/20/2003US20030216442 Substituted naphthylenes for the treatment of non-insulin dependent diabetes mellitus
11/20/2003US20030216440 Process for preparing arylacetylaminothiazoles
11/20/2003US20030216437 Thrombin receptor antagonists
11/20/2003US20030216432 Non-insulin sensitive diabetes; anticancer agents ; therapy, medical diagnosis
11/20/2003US20030216409 Heteroaryl alkyl piperazine derivatives
11/20/2003US20030216403 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent as well as treats asthma
11/20/2003US20030216394 Etylene derivatives and pesticides containing said derivatives
11/20/2003US20030216391 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
11/20/2003US20030216390 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
11/20/2003US20030216388 Cyclocarbamate derivatives as progesterone receptor modulators
11/20/2003US20030216385 Triazole derivatives
11/20/2003US20030216383 Compounds useful as reversible inhibitors of cysteine proteases
11/20/2003US20030216373 Activity against both Gram-positive and Gram-negative pathogens are generally regarded as having a broad spectrum of activity
11/20/2003US20030216258 Condensed heterocylic compounds and herbicides containing them as active ingredients
11/20/2003US20030216257 1-aryl-4-alkyl halide-2(1h)-pyridones and their use as herbicides
11/19/2003EP1362856A1 Water-soluble triazole fungicide
11/19/2003EP1362046A1 Substituted pyrimidinone derivatives as ligands of integrin receptors
11/19/2003EP1362044A1 Phthalazinone-piperidino-derivatives as pde4 inhibitors
11/19/2003EP1362042A1 Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1361875A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1361873A2 Matrix metalloproteinase inhibitors
11/19/2003EP1157023B1 C-21 modified epothilones
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0870765B1 Aminothiazole derivatives, drug containing the same and intermediate in the production of the compounds
11/19/2003CN1457339A Chemokine receptor binding heterocyclic compounds
11/18/2003US6649767 Contacting an enamine compound with a ketonic compound in presence of a base, treating the reaction mixture thus obtained with an acid or combinations of acids
11/18/2003US6649643 Imidazol-4-ylmehanols and their use as inhibitors of steroid C17-20 lyase
11/18/2003US6649641 Glucagon antagonists/inverse agonists
11/18/2003US6649640 Isoxazole compositions useful as inhibitors of ERK
11/18/2003US6649636 Cyclooxygenase inhibitors
11/18/2003US6649634 Use in treating diabetes, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemias, hyperlipidemia, atherosclerosis and myocardial ischemia in mammals
11/18/2003US6649633 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
11/18/2003US6649622 Treating diabetes, especially Type II diabetes
11/18/2003US6649618 Substituted amidoalkyl-uracils and their use
11/18/2003US6649608 Cyclin-dependent serine/threonine and focal adhesion kinase inhibitors
11/18/2003US6649603 For therapy of metabolic disorders related to insulin resistance or hyperglycemia
11/18/2003US6649366 Methods and compositions related to modulators of annexin and cartilage homeostasis
11/13/2003WO2003093297A2 Protein kinase modulators and methods of use
1 ... 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 ... 628